SCHEMBL15823927

SCHEMBL15823927

CN(CCCCC(=O)Nc1ccc(CO)cc1)C(=O)CCCc1ccc(-c2ccccc2)c(NC(=O)O)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
NPC1 O15118 3/20 0.45
RAB9A P51151 3/20 0.45
MAPT P10636 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
ALOX15 P16050 1/20 0.45
NFKB1 P19838 1/20 0.45
MAPK1 P28482 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
MCL1 Q07820 1/20 0.45
HDAC1 Q13547 6/20 0.41
HDAC2 Q92769 6/20 0.41
HDAC3 O15379 5/20 0.41
HDAC4 P56524 5/20 0.41
HDAC7 Q8WUI4 5/20 0.41
HDAC10 Q969S8 5/20 0.41
HDAC11 Q96DB2 5/20 0.41
HDAC8 Q9BY41 5/20 0.41
HDAC6 Q9UBN7 5/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15823627 0.91 ALDH1A1 (0.42) ALDH1A1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL101223 0.88 HDAC1 (0.51) ALDH1A1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL101623 0.87 HDAC2 (0.48) ALDH1A1MAPTSMN1; SMN2HDAC1HDAC2
SCHEMBL98704 0.82 AKR1C3 (0.51) NPC1RAB9AMAPTSMN1; SMN2HDAC1
SCHEMBL15823604 0.81 ALDH1A1 (0.39) ALDH1A1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL99035 0.80 HDAC1 (0.51) ALDH1A1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL99412 0.80 HCAR2 (0.47) ALDH1A1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL15822177 0.79 HDAC1 (0.47) ALDH1A1NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL100635 0.78 MEN1 (0.48) NPC1RAB9AHDAC1HDAC2HDAC3
SCHEMBL21314003 0.77 CHRM3 (0.67)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2934594-B1 CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES . ALMIRALL SA (ES) 2019-09-04 EP disclosed
EP-2934594-A1 NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITY Almirall, S.A. (ES) 2015-10-28 EP disclosed
WO-2014095920-A1 NEW CYCLOHEXYL AND QUINUCLIDINYL CARBAMATE DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITY ALMIRALL, S.A. (ES) 2014-06-26 WO disclosed